Van Bael & Bellis partners speak on EU competition law developments in the pharmaceutical sector during podcast
Van Bael & Bellis competition partners David Hull and Michael Clancy spoke about recent EU competition law developments in the pharmaceutical sector during a podcast hosted by Wolters Kluwer.
Topics discussed included new competition law developments regarding Covid IP waivers, patent settlements, patent late life cycle strategies, biosimilars, excessive pricing and merger control.
You can listen to the podcast on Wolters Kluwer Competition Law Blog here.
Related insightsSign up for updates